Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05454852
What this trial is testing

Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia

Who this might be right for
HIV
Boston University 771
Post-approval studies (Phase 4)UnknownNCT05726734
What this trial is testing

Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial

Who this might be right for
Helicobacter Pylori Infection
Shanghai East Hospital 100
Not applicableStudy completedNCT06913764
What this trial is testing

First- or Second- Class Compression Hosiery After Endovenous Laser With Sclerotherapy and Ambulatory Phlebectomy

Who this might be right for
Varicose VeinsChronic Venous DisorderChronic Venous Insufficiency (CVI)+2 more
Moscow City Hospital named after A.K. Eramishantsev 100
Not applicableStudy completedNCT03544463
What this trial is testing

Pivotal Study of the iNAP® in Adults With OSA

Who this might be right for
Obstructive Sleep Apnea
Somnics, Inc. 32
Not applicableUnknownNCT04216121
What this trial is testing

LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib

Who this might be right for
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Universitaire Ziekenhuizen KU Leuven 39
Not applicableStudy completedNCT05113238
What this trial is testing

Oocyte Activation: Revised or Initial AGT Technique, Which is Better?! A Sibling-oocytes-split Design

Who this might be right for
Assisted Reproductive Technology
Royal Fertility Center, Egypt 222
Early research (Phase 1)Looking for participantsNCT07652138
What this trial is testing

Safety and Efficacy of RN1201 Injection as First-Line Treatment for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MylomaNewly Diagnosed Multiple Myeloma (NDMM)
The First Affiliated Hospital of Soochow University 18
Testing effectiveness (Phase 2)Looking for participantsNCT07518602
What this trial is testing

Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma

Who this might be right for
Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
Sun Yat-sen University 34
Not applicableStudy completedNCT06547177
What this trial is testing

The Effect of Nutrition and Fluid Intake in the First Stage of Labor

Who this might be right for
Labor PainNutrient IntakeFluid Therapy
Hilal Yuvacı 90
Not applicableActive Not RecruitingNCT07774130
What this trial is testing

Comparison of Sodium Hypochlorite Gel and Solution With and Without Nanoparticles for Postoperative Pain After Pulpotomy in Permanent Mandibular Molars

Who this might be right for
Vital Pulp TherapiesPulpotomyIrriversible Pulpitis+1 more
Future University in Egypt 60
Testing effectiveness (Phase 2)Looking for participantsNCT07726446
What this trial is testing

Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors

Who this might be right for
Biliary Tract Cancer (BTC)
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableActive Not RecruitingNCT03442101
What this trial is testing

Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study

Who this might be right for
Psychosis
University of Alabama at Birmingham 156
Large-scale testing (Phase 3)Active Not RecruitingNCT05653219
What this trial is testing

Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

Who this might be right for
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals 152
Testing effectiveness (Phase 2)Study completedNCT01941407
What this trial is testing

First Line Metastatic Breast Cancer Treatment (ESMERALDA)

Who this might be right for
Metastatic Breast Cancer
ARCAGY/ GINECO GROUP 61
Testing effectiveness (Phase 2)Looking for participantsNCT06667167
What this trial is testing

First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy

Who this might be right for
NSCLC (non-small Cell Lung Cancer)
Nir Peled 21
Testing effectiveness (Phase 2)Study completedNCT00353145
What this trial is testing

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Who this might be right for
Unknown Primary Neoplasms
M.D. Anderson Cancer Center 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Ended earlyNCT00351039
What this trial is testing

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableUnknownNCT05094375
What this trial is testing

Vaginal Misoprostol In Medical Treatment of First Trimester Missed Miscarriage

Who this might be right for
Miscarriage
hany farouk 200
Early research (Phase 1)Study completedNCT01225302
What this trial is testing

Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie 12
Next Page